Philips North America has been the subject of 357 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company.
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: 0 warning letters, 2 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 357 recalls, 0 approval records, 0 Form 483s.
Side by side
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Warning letters0
Philips North America — Warning letters0
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Recalls2
Philips North America — Recalls357
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Approval records0
Philips North America — Approval records0
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Form 483s0
Philips North America — Form 483s0
Timeline
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Most recent FDA action: September 30, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed October 6, 2026. https://argushq.ai/compare/insight-pharmaceuticals-llc-a-prestige-consumer-healthcare-company-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗